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Abstract
Background: Blepharospasm can be present as an isolated dystonia or in conjunction with other forms of cranial dystonia, causing significant disability.
Case Report: We report a case of a 69-year-old male with craniocervical dystonia, manifesting primarily as incapacitating blepharospasm refractory to medical
treatments. He underwent bilateral globus pallidus (GP) deep brain stimulation (DBS) with complete resolution of his blepharospasm and sustained benefit at
12 months postoperatively.
Discussion: This case illustrates successful treatment of blepharospasm with pallidal stimulation. GP-DBS should be considered a reasonable therapeutic option
for intractable blepharospasm.
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Introduction
Deep brain stimulation (DBS) has an established role for treatment
of primary generalized and cervical dystonia, but historically it has
been considered to be relatively less effective for cranial and axial
dystonia.1–4 Cranial dystonia has variable clinical manifestations,
either blepharospasm alone, oromandibular dystonia alone, or both in
combination, with the last one being termed Meige syndrome. Pallidal
DBS for Meige syndrome has previously been described in case reports
or small case series, with improvement in dystonia rating scales ranging
from 45% to 89%, and with follow up ranging from 1 to 6 years.5–10
The results of these studies encourage the use of DBS in this popula-
tion of patients.
Whether blepharospasm is focal or part of Meige syndrome, it can
be the most incapacitating symptom. Blepharospasm is characterized
by prolonged tonic and clonic spasms of eye closure, caused by recur-
rent contractions of orbicularis oculi.11 Blepharospasm can also less
frequently resemble apraxia of eyelid opening with inability to open
the eyes. There have been rare case reports of using globus pallidus
interna (GPi) DBS for isolated blepharospasm.12,13 Table 1 sum-
marizes the results of pallidal DBS in cases of isolated blepharospasm
and the results of DBS on blepharospasm specifically in cases of Meige
syndrome. Although traditionally it is rare to perform DBS for patients
whose only major dystonic feature is blepharospasm, we demon-
strate another successful outcome of pallidal stimulation for primarily
blepharospasm in a patient with Meige syndrome.
Case report
A 69-year-old male presented with an 8–9-year history of blephar-
ospasm that began gradually and became debilitating. He had subtle
intermittent activation of lower facial muscles and slight torticollis,
prompting the diagnosis of Meige syndrome. His primarily tonic/
clonic blepharospasm progressed until he was functionally blind unless
he manually held his eyelids or taped them open (Figure 1A). He wore
ptosis crutches mounted on eyeglasses with minimal relief. Over the
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course of 6 years, he was injected numerous times with botulinum
toxin but with minimal benefit. A variety of toxins, including
onabotulinumtoxinA (up to 75 units), incobotulinumtoxinA (up to 100 units),
and abobotulinumtoxinA (up to 280 units), had been injected in the
upper face muscles (orbicularis oculi, pretarsal orbicularis, corrugator,
procerus, and frontalis). Clonazepam, up to 2 mg total daily, provided
no appreciable benefit, and the dose could not be increased dose
further because of sedation. He was reluctant to try other oral
medications because of concern about similar side effects. His severe
blepharospasm progressed, significantly impairing his quality of life,
Table 1. Published Cases of Pallidal DBS in Meige Syndrome and Isolated Blepharospasm
Number of
Patients
Indication for DBS Follow-up Duration
(months)
Improvement in
Blepharospasm (%)1
Reference no.
1 Meige 6 Improved but not quantified 7
11 Meige 12 63 8
5 Meige 10–124 88 9
6 Meige 6 79 5
6 Meige 12 Improved in all patients but not
quantified
10
12 Meige 12–78 55 6
1 Isolated blepharospasm 1 63 12
1 Isolated blepharospasm 15 88 13
Abbreviations: DBS, Deep Brain Stimulation.
1Each reference describes improvement in the Burke–Fahn–Marsden Dystonia Rating Scale.
Figure 1. Subject Photographs and MRI Imaging. (A) Subject’s blepharospasm pre- and post implantation of DBS. Pre-DBS, the subject used tape to hold his
eyelids open. (B) T2-weighted MRI showing trajectory planning and T1-weighted images showing electrode placement in bilateral GP. DBS, Deep Brain
Stimulation; GP, Globus Pallidus; MRI, Magnetic Resonance Imaging.
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as he could no longer do activities he enjoyed such as driving, sailing,
scuba diving, and biking.
The patient was evaluated for DBS and had neuropsychological
testing showing only mild deficits in attention and processing speed,
possibly because of distraction from blepharospasm, without other
significant concerns. He had a history of depression but was stable
on an antidepressant. Magnetic resonance imaging (MRI) of the brain
was normal and did not reveal an alternate etiology.
He underwent bilateral pallidal DBS placement using 1.5 T MRI-
based direct targeting and microelectrode recordings with intraoperative
test stimulation to determine thresholds for stimulation-induced adverse
effects, as has been previously described.14 Medtronic DBS leads
model 3387 (Medtronic Inc., Minneapolis, MN) were implanted, with
the lowest contacts corresponding to the last recorded cell of the globus
pallidus interna (GPi) and the highest contacts in the dorsal globus
pallidus externa (GPe). Lead tip location was measured relative to the
midcommissural point. A dual channel pulse generator (Medtronic
Activa PC) was implanted in the chest wall. A postoperative MRI
scan was performed to verify electrode position within the pallidum.
No complications were observed during or after the operation.
Initial DBS programming occurred on postoperative day 10. After
monopolar review, optimal DBS settings were found to be with mono-
polar stimulation using contact 1 and 9, pulse width 90 ms, frequency
150 Hz, and voltage 3.5 volts bilaterally. The coordinates of the active
contacts with respect to the midcommissural point for left and
right GPi respectively were lateral 22.2 mm and 20.9 mm, anterior–
posterior 4.8 mm and 6.5 mm, and ventral –4.2 mm and –2.0 mm.
Postoperative images of electrode placement are shown in Figure 1B.
The patient’s pre- and postoperative scores for the Burke–Fahn–
Marsden Dystonia Rating Scale (BFMDRS) and Jankovic Rating Scale
(JRS) are described in Table 2. Over the first month, he had 50–60%
improvement in dystonia (BFMDRS total motor score improved from
15 at baseline to 6; BFMDRS blepharospasm score improved from
8 at baseline to 4; JRS improved from 8 to 4). At his 1-year follow-up
visit, he reported 100% improvement in blepharospasm (BFMDRS
blepharospasm and JRS scores improved to 0). BFMDRS total motor
score improved to 1.5 or by 90% compared with baseline, and BFMDRS
disability score improved from 8 at baseline to 2 or by 80% compared
with baseline. His postoperative photograph and video show complete
resolution of blepharospasm (Figure 1A, Video 1). He also had 88%
improvement in his mild baseline cervical dystonia, with BFMDRS neck
subscore improving from 4 at baseline to 0.5 at 1- month and 1-year
follow ups. He no longer requires oral medications or botulinum toxin
injections for blepharospasm. He did not report any stimulation-induced
side effects over one year and has not required programming adjustments
since his 1-month postoperative visit.
Discussion
This case demonstrates successful use of pallidal DBS for intractable
and debilitating blepharospasm. While botulinum toxin injections
remain the first-line treatment for blepharospasm and many patients
respond well to it, there are limited alternative options available if
injections fail. This case illustrates that pallidal DBS should be con-
sidered in patients refractory to medical treatments and experiencing
significant disability.
Table 2. Dystonia Severity at Baseline and Follow-up
Baseline 1 Month Post Operation
(improvement from baseline)
1 Year Post Operation
(improvement from baseline)
BFMDRS total movement score 15 6 (60%) 1.5 (90%)
BFMDRS blepharospasm score 8 4 (50%) 0 (100%)
BFMDRS neck score 4 0.5 (88%) 0.5 (88%)
BFMDRS disability score 10 2 (80%) 2 (80%)
JRS score 8 4 (50%) 0 (100%)
Abbreviations: BFMDRS, Burke–Fahn–Marsden Dystonia Rating Scale; JRS, Jankovic Rating Scale.
Video 1. Segment 1A. Examination of the Subject’s Blepharospasm Prior to
Deep Brain Stimulation. There are frequent spasms and difficulty keeping eyes
open. Patient requires tape or use of hands to hold his eyelids open. Segment 1B.
Examination of Patient’s Blepharospasm 1 Year after Deep Brain Stimulation
Implantation. The patient is able to hold his eyes open easily and there are no
spasms or contractions seen.
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Mu¨ller et al.15 have reported poor health-related quality of life and
depression in patients with blepharospasm. Patients report not only
a decline in physical functioning but also significant social stigma
from blepharospasm. Improvement from commonly used drugs such
as anticholinergics, benzodiazepines, baclofen, and tetrabenazine is
modest at best and can cause problematic side effects such as sedation.
Patient satisfaction with botulinum toxin injections is usually very high,
but most patients feel a considerable decline in treatment effects at
8–10 weeks after injection.16 With repeated use of botulinum toxin
injections, there is also the risk of developing immunity to the drug.
DBS has emerged as a treatment option for Meige syndrome,
although the number of patients studied is small. Most prior studies
describe patients with craniocervical dystonia treated with DBS, often
with the most significant improvement in cervical dystonia and an
overall improvement of 50–75% on dystonia rating scales.5–10,17,18
The specific improvement in blepharospasm in these cases ranges from
55% to 88% (Table 1). Our results show similar and substantial
improvement of 100% at 12 months. While GPi is the most commonly
used target for Meige syndrome, subthalamic nucleus DBS has also
been reported.17 Reports of patients receiving DBS for isolated
blepharospasm or primarily blepharospasm are rare. Santos et al.13
described pallidal stimulation for isolated blepharospasm, with loss of
benefit unilaterally at 7 months postoperatively, which was attributed
to a more laterally placed electrode in the GPe. Troubleshooting the
electrode with interleaved programming resulted in 63% improvement
in blepharospasm. Yamada et al.12 reported the second case of pallidal
stimulation for isolated blepharospasm with 88% improvement at
15 months. Our results are similar to the above two case reports for
isolated blepharospasm.
Given the previously reported benefit of DBS for Meige syn-
drome and the recent case reports of pallidal stimulation for isolated
blepharospasm, DBS should be considered a potential therapy for
medically refractory blepharospasm. A larger case series with extended
follow-up will be helpful in determining the long-term efficacy of DBS
for blepharospasm.
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